Extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a Dublin paediatric hospital

British Journal of Biomedical Science

Volumn 55, Issue 2, 1998, Pages 111-117

  Grogan, Juanita ^a   Murphy, Helen ^a   Butler, Karina ^a  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

Beta lactamases; Klebsiella pneumoniae

Indexed keywords

BETA LACTAMASE; CEPHALOSPORIN DERIVATIVE; GENTAMICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD CULTURE; DIFFUSION; ENZYME ASSAY; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; NONHUMAN; PLASMID; PRIORITY JOURNAL; SCREENING; URINE;

BETA-LACTAMASES; CHILD, PRESCHOOL; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; INFANT; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE;

KLEBSIELLA PNEUMONIAE; NEGIBACTERIA;

EID: 0031821662     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Philippon A, Arlet G, Lagrange PH. Origin and impact of plasmid mediated extended spectrum beta-lactamases. Rev Eur J Clin Microbiol Infect Dis 1994; 13(Suppl 1):17-29.
2. Ehrhardt AF, Sanders CC. Beta-lactam resistance amongst Enterobacter species. J Antimicrob Chemother 1993; 32(Suppl B):1-11.
3. Jacoby GA, Medeiros AA. More extended spectrum beta-lactamases. Antimicrob Agents Chemother 1991; 35:1697-704.
4. Bauernfeind A, Horl G. Novel R-factor-borne β-lactamase of Escherichia coli conferring resistance to cephalosporins. Infection 1987; 15:257-9.
5. Gould IM. Risk factors for acquisition of multiple drug-resistant Gram-negative bacteria. Rev Eur J Clin Microbiol Infect Dis 1994; 13(Suppl 1):30-8.
6. British Society of Antimicrobial Chemotherapy Working Party. A guide to sensitivity testing. J Antimicrob Chemother 1991; 27(Suppl D):1-50.
7. Palfreyman JM. Klebsiella serotyping by counter-current immunoelectrophoresis. J Hygiene 1978; 81:219-25.
8. Kaufman ME, Pitt TL. Pulsed-field gel electrophoresis of bacterial DNA. In: Chart H, ed. Methods in practical laboratory bacteriology. Boca Raton, FL: CRC Press, 1994: Ch 8.
9. Kado CI, Liu ST. Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol 1981; 145:1365-73.
10. Livermore DM. Determinants of the activity of beta-lactamase inhibitor combinations. J Antimicrob Chemother 1993; 31(Suppl A):9-21.
11. Sanders CC. Beta-lactamases of Gram-negative bacteria. New challenges for new drugs. Rev Clin Infect Dis 1992; 14:1089-99.
12. Jacoby GA. Genetics of extended spectrum beta-lactamases. Rev Eur J Clin Microbiol Infect Dis 1994; 13(Suppl 1):2-11.
13. Livermore DM. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8:557-84.
14. Jacoby GA, Han P. Detection of extended spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia cali. J Clin Microbiol 1996; 34:908-11.
15. Casewell MW, Desai N. Survival of multiple resistant Klebsiella aerogenes and other Gram-negative bacteria on fingertips. J Hosp Infect 1983; 4:350-60.
16. Darfeuille-Michaud A et al. R-plasmid-encoded adhesive factor in Klebsiella pneumoniae strains responsible for human nosocomial infections. Infect Immun 1992; 60:44-55.
17. Pornull KJ, Rodrigo G, Dornbusch K. Production of a plasmid mediated AmpC-like β-lactamase by a Klebsiella pneumoniae septicaemia isolate. J Antimicrob Chemother 1994; 34:943-54.